Emanuele Vivarelli

778 total citations
33 papers, 336 citations indexed

About

Emanuele Vivarelli is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Emanuele Vivarelli has authored 33 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Rheumatology. Recurrent topics in Emanuele Vivarelli's work include Asthma and respiratory diseases (20 papers), Allergic Rhinitis and Sensitization (7 papers) and Drug-Induced Adverse Reactions (6 papers). Emanuele Vivarelli is often cited by papers focused on Asthma and respiratory diseases (20 papers), Allergic Rhinitis and Sensitization (7 papers) and Drug-Induced Adverse Reactions (6 papers). Emanuele Vivarelli collaborates with scholars based in Italy and United States. Emanuele Vivarelli's co-authors include Alessandra Vultaggio, Andrea Matucci, Francesca Nencini, Enrico Maggi, Paola Parronchi, Oliviero Rossi, Lorenzo Salvati, Benedetta Biagioni, Oreste Gallo and Giandomenico Maggiore and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Emanuele Vivarelli

31 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuele Vivarelli Italy 11 145 130 99 70 66 33 336
A. Prudhomme France 12 318 2.2× 336 2.6× 60 0.6× 79 1.1× 119 1.8× 31 508
Faiz Karim Netherlands 11 40 0.3× 21 0.2× 275 2.8× 49 0.7× 29 0.4× 23 419
Jennifer Harvey United Kingdom 9 34 0.2× 171 1.3× 78 0.8× 96 1.4× 29 0.4× 13 405
Robert W. King United States 7 44 0.3× 196 1.5× 9 0.1× 110 1.6× 29 0.4× 12 466
Elizabeth Shay United States 9 46 0.3× 52 0.4× 13 0.1× 33 0.5× 9 0.1× 19 318
Noriko Seko Japan 7 126 0.9× 51 0.4× 81 0.8× 252 3.6× 40 0.6× 15 381
Georges El Hasbani Lebanon 11 19 0.1× 51 0.4× 113 1.1× 82 1.2× 6 0.1× 60 343
Iwona Homa‐Mlak Poland 12 69 0.5× 75 0.6× 15 0.2× 63 0.9× 5 0.1× 37 289
Chynna Huang Canada 8 399 2.8× 155 1.2× 44 0.4× 370 5.3× 68 1.0× 21 576
Julia A. Ford United States 10 39 0.3× 109 0.8× 205 2.1× 37 0.5× 6 0.1× 19 292

Countries citing papers authored by Emanuele Vivarelli

Since Specialization
Citations

This map shows the geographic impact of Emanuele Vivarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Vivarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Vivarelli more than expected).

Fields of papers citing papers by Emanuele Vivarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Vivarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Vivarelli. The network helps show where Emanuele Vivarelli may publish in the future.

Co-authorship network of co-authors of Emanuele Vivarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Vivarelli. A scholar is included among the top collaborators of Emanuele Vivarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Vivarelli. Emanuele Vivarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vivarelli, Emanuele, Manlio Milanese, Giandomenico Maggiore, et al.. (2025). Asthma Phenotype Can Be Influenced by Recurrent Respiratory Infections in Patients with Primary Antibody Deficiency: The Impact of Ig Therapy. Respiration. 104(7). 457–465.
2.
Matucci, Andrea, Giandomenico Maggiore, Emanuele Vivarelli, et al.. (2025). Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations. Journal of Investigational Allergology and Clinical Immunology. 36(4). 0–0.
3.
Salvati, Lorenzo, Boaz Palterer, Elena Lazzeri, et al.. (2024). Presentation and progression of MPO-ANCA interstitial lung disease. Journal of Translational Autoimmunity. 8. 100235–100235. 4 indexed citations
4.
Vivarelli, Emanuele, et al.. (2024). Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study. European Archives of Oto-Rhino-Laryngology. 282(1). 265–272. 2 indexed citations
5.
Vultaggio, Alessandra, Emanuele Vivarelli, Giandomenico Maggiore, et al.. (2023). Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab. Allergy. 78(12). 3154–3165. 21 indexed citations
6.
Salvati, Lorenzo, Emanuele Vivarelli, Alessandra Vultaggio, et al.. (2023). Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis. Antibodies. 12(1). 13–13. 3 indexed citations
7.
Vivarelli, Emanuele, Ersilia Lucenteforte, Gianni Virgili, et al.. (2022). Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study. Panminerva Medica. 65(4). 473–478. 1 indexed citations
8.
Vivarelli, Emanuele, et al.. (2022). Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case series. The Journal of Allergy and Clinical Immunology In Practice. 10(12). 3317–3319. 2 indexed citations
9.
Matucci, Andrea, et al.. (2021). Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?. International Journal of Molecular Sciences. 22(7). 3340–3340. 34 indexed citations
10.
Matucci, Andrea, Luisa Bercich, Camilla Comin, et al.. (2021). Effect of dupilumab treatment in a severe asthma patient with EGPA. The Journal of Allergy and Clinical Immunology In Practice. 9(10). 3824–3825. 10 indexed citations
11.
Vultaggio, Alessandra, Federica Tomao, Francesca Nencini, et al.. (2021). The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer. Gynecologic Oncology Reports. 38. 100880–100880. 6 indexed citations
12.
Vultaggio, Alessandra, Francesca Nencini, Elena Silvestri, et al.. (2021). Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis. Scientific Reports. 11(1). 12558–12558. 9 indexed citations
13.
Matucci, Andrea, Emanuele Vivarelli, Francesca Nencini, Enrico Maggi, & Alessandra Vultaggio. (2021). Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors. Biomedicines. 9(10). 1497–1497. 18 indexed citations
14.
Vultaggio, Alessandra, Francesca Nencini, Camilla Comin, et al.. (2021). Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA. Journal of Investigational Allergology and Clinical Immunology. 31(6). 519–521. 10 indexed citations
15.
Vultaggio, Alessandra, et al.. (2021). How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?. Frontiers in Immunology. 12. 765747–765747. 18 indexed citations
16.
Caminati, Marco, Alessandra Vultaggio, Andrea Matucci, et al.. (2020). Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respiratory Medicine. 176. 106261–106261. 38 indexed citations
17.
Bruno, Chiara, Luca Giovanni Locatello, Alessandra Vultaggio, et al.. (2020). Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19. Allergy & Rhinology. 11. 1911221360–1911221360. 3 indexed citations
18.
Vultaggio, Alessandra, et al.. (2020). Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1764–1767.e1. 13 indexed citations
19.
Salvati, Lorenzo, Benedetta Biagioni, Emanuele Vivarelli, & Paola Parronchi. (2020). A gendered magnifying glass on COVID-19. Clinical and Molecular Allergy. 18(1). 14–14. 20 indexed citations
20.
Matucci, Andrea, Francesco Liotta, Emanuele Vivarelli, et al.. (2018). Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome. Frontiers in Immunology. 9. 1198–1198. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Prudhomme Breakdown of academic impact, for papers by Faiz Karim Breakdown of academic impact, for papers by Jennifer Harvey Breakdown of academic impact, for papers by Robert W. King Breakdown of academic impact, for papers by Elizabeth Shay Breakdown of academic impact, for papers by Noriko Seko Breakdown of academic impact, for papers by Georges El Hasbani Breakdown of academic impact, for papers by Iwona Homa‐Mlak Breakdown of academic impact, for papers by Chynna Huang Breakdown of academic impact, for papers by Julia A. Ford
Rankless by CCL
2026